How a drug tracer moves through healthy men
Part of Heart & circulation clinical trials.
This study uses a tiny amount of radioactive tracer in an injection to see how the drug moves through the body and leaves it. It is only for healthy men between 18 and 45.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy male between 18 and 45 years old.
- You weigh at least 50 kg (about 110 lbs) and have a body mass index (BMI) between 19 and 28.
- You agree to use effective birth control during the study and for a period after.
- You have no history of drug allergies, heart rhythm problems, or liver or kidney issues.
- You have not had recent radiation exposure (like many X-rays or CT scans) or taken other medications recently.
- You have no active infections like hepatitis B, C, or HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a single dose of an investigational drug called HRS-1893 is processed and removed from the body in healthy men. You'll stay at the clinic and provide blood and urine samples for several days.
This study tests how a healthy male body absorbs, uses, and removes a new experimental medication. Researchers track the drug's path through your body using a special radioactive marker to understand how it works and ensure it's safe.
This study tracks how a new experimental drug (HRS-1780) moves through and leaves your body. Researchers will give you a single dose and measure where it goes and how it's eliminated, which helps them understand if it's safe for future patients.
This is an early-stage safety study of an experimental drug called HRS-7156 in people with no serious health conditions. Researchers will monitor how your body tolerates the drug and how it moves through your system.
This study looks at how a drug called HS-10504 is processed and eliminated from the body. Healthy male volunteers take one dose so researchers can track where the drug goes. It helps determine the right dosing and safety for future patients.
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
Hear when a new Fluid Retention Due to Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.